BackEvelo Biosciences Overview

Evelo Biosciences Operating Income

Operating Income for EVLO.

Quarterly Operating Income

$-11183000.00
61.51% YoY

As of Sep 30, 2023

Annual Operating Income (TTM)

$-76744000.00
33.23% YoY

Trailing 12 months ending Sep 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)